This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Obesity is one of the world’s biggest health crisis and only seems to be getting worse. For over 50 years, the rates of obesity have continued to rise worldwide 1. The most recent data on obesity has shown a decline for the first time in a very long time. Between 2020 and 2023, the rates of obesity dropped by about 2% 2.
For over 50 years, rates of those who are overweight or obese have been rising rapidly. Despite the rise in obesity rates, the growing recognition of it as a global problem and the astronomical sums of money we spend on addressing it, the tide continues to rise. That is until now.
That’s what the field of obesity therapeutics feels like right now. There is even emerging evidence that the use of such therapies may even reduce the risk of colorectal cancer by up to 50% 6. Subscribe now 1 [link] 2 [link] 3 Retatrutide Phase 2 Obesity Trial Investigators. 2023 Aug 10;389(6):514-526. 2023 Nov 11.
More than heart disease or cancer, the risk of dementia often creates much greater anxiety in the patients I see. Obesity The relationship between obesity and dementia is not straightforward and likely depends on when a person becomes obese and also whether there is significant metabolic dysfunction with the obesity.
Similar patterns have been observed for cardiovascular disease and also cancer. More steps are linked to: Less obesity. occupation-related physical activity and their associations with obesity. 2023 Apr;7(4):e313-e328. Taking 12,000-a-day steps led to a 65% reduction 5. The relationship is clear. More movement.
It kills almost twice as many people globally when compared to all cancers combined. For other significant risk factors, the trend is also the same, with almost nonexistent rates of obesity, abnormal glycemic control and very low rates of smoking 14. 2023 Jan;19(1):44-55. Over 80% of early heart disease is preventable.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionEndovascular intervention has become the mainstay of treatment for acute ischemic stroke. However, in certain cases, open surgery is the only option to achieve revascularization. Clinical data were reviewed retrospectively.ResultsCase 1.
24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 Atrial Fibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24 12:15 p.m.
Food and Drug Administration ( FDA ) has approved an additional indication for Wegovy ( semaglutide ) to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight along with a reduced calorie diet and increased physical activity.
Let’s start with the simple fact that a lot of cancer diagnoses are simply down to ‘bad luck’ You can do everything right and still get cancer. Cancer - Less so. If exercise reduces all-cause mortality, it seems safe to say that it is reducing cardiovascular and cancer deaths.
In the Sunday Times of April 23 rd , 2017, this article appeared, entitled ‘ Kellogg’s smothers health crisis in sugar – The cereals giant is funding studies that undermine official warnings on obesity.’ The study, published in the Journal Obesity Facts relied on evidence from 14 studies. Just to choose a few paragraphs. ‘
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content